Evaluation of the Learning Curve in Robotic Nipple-sparing Mastectomy for Breast Cancer

Zhu-Jun Loh,Tzu-Yi Wu,Fiona Tsui-Fen Cheng
DOI: https://doi.org/10.1016/j.clbc.2020.09.013
IF: 3.078
2021-06-01
Clinical Breast Cancer
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aim</h3><p>The preliminary results of the robotic nipple sparing mastectomy (R-NSM) in patients with breast cancer and analyze the learning curve of the same surgeon in a single medical center.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Method</h3><p>Patients with breast cancer between 2018 to 2020 from a single center who received R-NSM were recruited for clinical and pathological tumour characteristics including family history, grade, type of tumour, treatment and outcome. The learning curve for R-NSM was analyzed by using cumulative sum (CUSUM).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>A total of 85 R-NSM procedures from 78 patients were evaluated. In CUSUM plot analysis of the learning curve, a significant decrease in time for mastectomy, reconstruction and total operation appeared in the 22<sup>nd</sup>, 23<sup>rd</sup>, 26<sup>th</sup> procedures, respectively. Patients' body weight, gel implant size, and specimen weight had significant correlations with the time for mastectomy. Four patients (5.6%) had nipple partial ischemia, and one (1.4%) had total nipple necrosis. The mean follow-up of 11.4 ± 6.2 months, only one patients showed recurrence.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Robotic breast surgery is a feasible method with good cosmetic outcome under suitable patient selection. Oncologic safety is not a reason to stop its development.</p>
oncology
What problem does this paper attempt to address?